NeoGenomics (NEO) Competitors

Bilibili (NASDAQ:BILI) and NeoGenomics (NASDAQ:NEO) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk, dividends, media sentiment and valuation.

Do analysts rate BILI or NEO?

Bilibili presently has a consensus price target of $19.69, suggesting a potential upside of 5.07%. NeoGenomics has a consensus price target of $20.25, suggesting a potential upside of 33.49%. Given NeoGenomics' stronger consensus rating and higher possible upside, analysts clearly believe NeoGenomics is more favorable than Bilibili.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bilibili	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.93
NeoGenomics	0 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility and risk, BILI or NEO?

Bilibili has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, NeoGenomics has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500.

Do institutionals and insiders believe in BILI or NEO?

16.1% of Bilibili shares are owned by institutional investors. Comparatively, 98.5% of NeoGenomics shares are owned by institutional investors. 22.2% of Bilibili shares are owned by insiders. Comparatively, 1.3% of NeoGenomics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is BILI or NEO more profitable?

Bilibili has a net margin of -10.73% compared to NeoGenomics' net margin of -12.07%. NeoGenomics' return on equity of -2.11% beat Bilibili's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bilibili	-10.73%	-15.17%	-6.66%
NeoGenomics	-12.07%	-2.11%	-1.18%

Does the media prefer BILI or NEO?

In the previous week, Bilibili had 16 more articles in the media than NeoGenomics. MarketBeat recorded 21 mentions for Bilibili and 5 mentions for NeoGenomics. Bilibili's average media sentiment score of 0.64 beat NeoGenomics' score of 0.31 indicating that Bilibili is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bilibili	7 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
NeoGenomics	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Which has higher earnings and valuation, BILI or NEO?

NeoGenomics has lower revenue, but higher earnings than Bilibili. NeoGenomics is trading at a lower price-to-earnings ratio than Bilibili, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bilibili	$3.19B	2.44	-$679.21M	-$0.92	-20.37
NeoGenomics	$591.64M	3.29	-$87.97M	-$0.61	-24.87

Does the MarketBeat Community favor BILI or NEO?

NeoGenomics received 99 more outperform votes than Bilibili when rated by MarketBeat users. Likewise, 70.90% of users gave NeoGenomics an outperform vote while only 61.72% of users gave Bilibili an outperform vote.

Company	Underperform	Outperform
Bilibili	Outperform Votes 403 61.72%	Underperform Votes 250 38.28%
NeoGenomics	Outperform Votes 502 70.90%	Underperform Votes 206 29.10%

Summary

NeoGenomics beats Bilibili on 11 of the 18 factors compared between the two stocks.